Evidence map›Paper›PMID 34066527›Full record

ArticleInternational journal of molecular sciences2021

Cross-TCR Antagonism Revealed by Optogenetically Tuning the Half-Life of the TCR Ligand Binding.

Omid Sascha Yousefi, Matias Ruggieri, Vincent Idstein, Kai Uwe von Prillwitz, Laurenz A Herr, Julia Chalupsky, Maja Köhn, Wilfried Weber, Jens Timmer, Wolfgang W A Schamel

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Coupling Recombinant PhyB to Cell Culture Plates and Beads.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Extracellular Optogenetics to Interrogate Unmodified Primary Cell Functions.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Red Light Optogenetics in Neuroscience.Frontiers in cellular neuroscience · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Omid Sascha YousefiFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0001-5304-729X
Matias RuggieriFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Vincent IdsteinFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Kai Uwe von PrillwitzInstitute of Physics, University of Freiburg, 79104 Freiburg, Germany.
Laurenz A HerrFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0002-1035-2558
Julia ChalupskyFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0002-1729-0089
Maja KöhnFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.ORCID 0000-0001-8142-3504
Wilfried WeberFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Jens TimmerSignalling Research Centres BIOSS and CIBSS, 79104 Freiburg, Germany.ORCID 0000-0003-4517-1383
Wolfgang W A SchamelFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
University of Freiburg · DE

Funding

Deutsche Forschungsgemeinschaft EXC 2189Deutsche Forschungsgemeinschaft EXC294Deutsche Forschungsgemeinschaft GSC-4Deutsche Forschungsgemeinschaft SFB1381Deutsche Forschungsgemeinschaft SFB854
6 · The paper itself

Abstract

Activation of T cells by agonistic peptide-MHC can be inhibited by antagonistic ones. However, the exact mechanism remains elusive. We used Jurkat cells expressing two different TCRs and tested whether stimulation of the endogenous TCR by agonistic anti-Vβ8 antibodies can be modulated by ligand-binding to the second, optogenetic TCR. The latter TCR uses phytochrome B tetramers (PhyBt) as ligand, the binding half-life of which can be altered by light. We show that this half-life determined whether the PhyBt acted as a second agonist (long half-life), an antagonist (short half-life) or did not have any influence (very short half-life) on calcium influx. A mathematical model of this cross-antagonism shows that a mechanism based on an inhibitory signal generated by early recruitment of a phosphatase and an activating signal by later recruitment of a kinase explains the data.

Indexed as

OptogeneticsAntibodiesCell MembraneGreen Fluorescent ProteinsHalf-LifeHEK293 CellsHumansJurkat CellsLigandsModels, BiologicalReceptors, Antigen, T-CellAntibodiesGreen Fluorescent ProteinsLigandsReceptors, Antigen, T-Cellantagonismmodelingsignalingsynthetic biologyT cell activationTCR

Identifiers

PMID34066527
PMCPMC8124730
OpenAlexW3159938732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.